New report from NTI | bio offers recommendations for urgent actions that leaders within government, industry, the scientific community, and civil society should take to safeguard AI-bio capabilities.
Testimony of Jaime M. Yassif at U.S. House Hearing on "Strengthening Biosafety and Biosecurity Standards: Protecting Against Future Pandemics"
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
Practical solutions for organizations involved in life science research to manage risks and prevent accidents, misuse, and other adverse outcomes stemming from their work.
In an op-ed for The Hill, NTI Senior Advisor Angela Kane and Vice President for Global Biological Policy and Programs Jaime Yassif acknowledge the importance of the ongoing investigation into the source of the COVID-19 pandemic.
In a new opinion piece for The Economist, Jaime Yassif makes the case for urgent action to create stronger guardrails for bioscience and biotechnology.
On April 21, 2022, immediately after G20 finance ministers and central bank governors reached consensus to establish a new Fund for preparedness at the World Bank, a group of leading experts and stakeholders from met to review progress and offer advice on next steps. This paper aims to inform next steps to structure, approve, and launch a new Fund, including the forthcoming consultative process led by the World Bank.
Testimony of Jaime M. Yassif, Ph.D. before the U.S. House Foreign Affairs Subcommittee on Asia, the Pacific, Central Asia, and Nonproliferation. Hearing on “Biosecurity for the Future: Strengthening Deterrence and Detection.” Wednesday, December 8, 2021.
The first comprehensive assessment of global health security capabilities in 195 countries.
